(b)(4).(b)(4).(importer) evaluated the device and found that energy output was below the specifications.As per alma ltd.Clinical, this finding is not likely to contribute to the adverse event.Based on the initial photos and information provided by the facility, alma ltd.Clinical concluded that given the patient's dark skin, the combination of excessive fluence and suboptimal cooling on the skin before and after the treatment is the most likely root cause for this untoward skin reaction.The independent medical expert contacted by alma ltd found the injury to be reversible first-degree burns.Due to non-permanent nature of the injury, the event was deemed non-reportable at that time.(b)(4).Made multiple follow up attempts for patient's condition and the facility noted a positive response.However, on 08/18/2018, (b)(4).Received patient follow up photos from the facility.These were forwarded to alma ltd.For re-assessment.Upon review of the photos, alma ltd clinical concluded that patient still has hypopigmentation areas and per company reportability criteria this should be reported to the fda.
|